Showing 73 to 84 of 93 results
Medicare Selects 15 More Drugs for Price Negotiation
Medicare selected 15 more top-selling prescription drugs for price negotiations under the Inflation Reduction Act, impacting 5.3 million beneficiaries and $41 billion in spending, with expected savings of $1.5 billion in 2027, but the incoming Trump administration may alter the program.
Medicare Selects 15 More Drugs for Price Negotiation
Medicare selected 15 more top-selling prescription drugs for price negotiations under the Inflation Reduction Act, impacting 5.3 million beneficiaries and $41 billion in spending, with expected savings of $1.5 billion in 2027, but the incoming Trump administration may alter the program.
Progress
48% Bias Score
Medicare to Negotiate Prices for Ozempic, Wegovy, and 13 Other Drugs
Medicare will negotiate prices for Ozempic, Wegovy, and 13 other drugs, impacting 5.3 million Part D users and $41 billion in drug costs, with negotiated prices effective in 2027.
Medicare to Negotiate Prices for Ozempic, Wegovy, and 13 Other Drugs
Medicare will negotiate prices for Ozempic, Wegovy, and 13 other drugs, impacting 5.3 million Part D users and $41 billion in drug costs, with negotiated prices effective in 2027.
Progress
32% Bias Score
Future of Medicare Drug Price Negotiations Uncertain Under Trump
Medicare's new drug price negotiation program, enacted under the Inflation Reduction Act, faces an uncertain future under the incoming Trump administration; while it lowered prices on 10 drugs in 2023, and aims to lower prices on 15 more in 2027, Republican efforts to repeal it are underway.
Future of Medicare Drug Price Negotiations Uncertain Under Trump
Medicare's new drug price negotiation program, enacted under the Inflation Reduction Act, faces an uncertain future under the incoming Trump administration; while it lowered prices on 10 drugs in 2023, and aims to lower prices on 15 more in 2027, Republican efforts to repeal it are underway.
Progress
52% Bias Score
Australia's Economic Inequality: A Falling Healthcare System and a Widening Wealth Gap
Australia's healthcare system, once a world leader, has fallen to eighth place globally, reflecting a broader trend of increasing economic inequality where the top 10% of households hold 44% of the nation's wealth, while the lowest 20% possess only $41,000 on average.
Australia's Economic Inequality: A Falling Healthcare System and a Widening Wealth Gap
Australia's healthcare system, once a world leader, has fallen to eighth place globally, reflecting a broader trend of increasing economic inequality where the top 10% of households hold 44% of the nation's wealth, while the lowest 20% possess only $41,000 on average.
Progress
60% Bias Score
Australian Adults Pay More for GP Visits Despite Government Bulk-Billing Investment
Analysis of Medicare data reveals that while the Albanese government's \$3.5 billion investment in bulk billing increased free GP visits for children and older Australians, adults aged 16 to 64 are paying more for GP appointments, with bulk-billing rates declining and out-of-pocket costs rising from...
Australian Adults Pay More for GP Visits Despite Government Bulk-Billing Investment
Analysis of Medicare data reveals that while the Albanese government's \$3.5 billion investment in bulk billing increased free GP visits for children and older Australians, adults aged 16 to 64 are paying more for GP appointments, with bulk-billing rates declining and out-of-pocket costs rising from...
Progress
56% Bias Score
Biden's Healthcare Legacy: A Series of Setbacks
President Biden's healthcare initiatives have fallen short of expectations, marked by a $266 billion Medicare diversion, Medicaid disenrollments, rampant ACA fraud costing taxpayers billions, and inadequate cost-control measures, leaving millions uninsured and exacerbating systemic problems.
Biden's Healthcare Legacy: A Series of Setbacks
President Biden's healthcare initiatives have fallen short of expectations, marked by a $266 billion Medicare diversion, Medicaid disenrollments, rampant ACA fraud costing taxpayers billions, and inadequate cost-control measures, leaving millions uninsured and exacerbating systemic problems.
Progress
64% Bias Score
Medicare Price Negotiations Expand to 15 Drugs, Including Ozempic and Wegovy
The Biden administration announced 15 drugs, including Ozempic and Wegovy, for Medicare price negotiations under the Inflation Reduction Act, aiming to lower drug costs for 50 million beneficiaries; the new prices are expected to take effect in January 2027, although the incoming Trump administratio...
Medicare Price Negotiations Expand to 15 Drugs, Including Ozempic and Wegovy
The Biden administration announced 15 drugs, including Ozempic and Wegovy, for Medicare price negotiations under the Inflation Reduction Act, aiming to lower drug costs for 50 million beneficiaries; the new prices are expected to take effect in January 2027, although the incoming Trump administratio...
Progress
36% Bias Score
575 Brand-Name Drug Prices Increase in Early 2025
On January 1st and 2nd, 2025, 575 brand-name drugs increased in price, including Ozempic and Paxlovid; the median increase was 4%, exceeding inflation and potentially impacting consumer costs depending on insurance coverage and formulary placement.
575 Brand-Name Drug Prices Increase in Early 2025
On January 1st and 2nd, 2025, 575 brand-name drugs increased in price, including Ozempic and Paxlovid; the median increase was 4%, exceeding inflation and potentially impacting consumer costs depending on insurance coverage and formulary placement.
Progress
36% Bias Score
Social Security Fairness Act Increases Benefits for Millions, but Accelerates Trust Fund Depletion
President Biden signed the Social Security Fairness Act, eliminating benefit reductions for 2.1 million WEP-affected individuals and 770,000 spouses and surviving spouses affected by GPO, resulting in higher monthly checks and retroactive payments, at a cost of $196 billion over ten years.
Social Security Fairness Act Increases Benefits for Millions, but Accelerates Trust Fund Depletion
President Biden signed the Social Security Fairness Act, eliminating benefit reductions for 2.1 million WEP-affected individuals and 770,000 spouses and surviving spouses affected by GPO, resulting in higher monthly checks and retroactive payments, at a cost of $196 billion over ten years.
Progress
44% Bias Score
Social Security, Medicare Changes for 2025
In 2025, Social Security recipients will see a 2.5% cost of living increase, while some public pensioners will receive additional benefits due to the Social Security Fairness Act eliminating the Windfall Elimination Provision and Government Pension Offset. Medicare Part D will have a $2,000 annual o...
Social Security, Medicare Changes for 2025
In 2025, Social Security recipients will see a 2.5% cost of living increase, while some public pensioners will receive additional benefits due to the Social Security Fairness Act eliminating the Windfall Elimination Provision and Government Pension Offset. Medicare Part D will have a $2,000 annual o...
Progress
40% Bias Score
Labor Unveils Major Medicare Reforms Ahead of Australian Federal Election
Australia's Labor government is proposing major Medicare reforms ahead of the federal election, including increased bulk-billing incentives, expanded urgent care clinics, and GP workforce expansion, aiming to improve healthcare accessibility and affordability while contrasting its approach with the ...
Labor Unveils Major Medicare Reforms Ahead of Australian Federal Election
Australia's Labor government is proposing major Medicare reforms ahead of the federal election, including increased bulk-billing incentives, expanded urgent care clinics, and GP workforce expansion, aiming to improve healthcare accessibility and affordability while contrasting its approach with the ...
Progress
56% Bias Score
Medicare Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act of 2022 caps out-of-pocket Medicare Part D prescription drug costs at $2,000 annually starting in 2025, benefiting over 3 million enrollees initially, rising to over 4 million by 2029, with roughly 40% seeing annual savings of at least $1,000; insurers received roughly $5...
Medicare Drug Cost Cap Set at $2,000 Annually Starting in 2025
The Inflation Reduction Act of 2022 caps out-of-pocket Medicare Part D prescription drug costs at $2,000 annually starting in 2025, benefiting over 3 million enrollees initially, rising to over 4 million by 2029, with roughly 40% seeing annual savings of at least $1,000; insurers received roughly $5...
Progress
36% Bias Score
Showing 73 to 84 of 93 results